Author:
Ramakrishnan Veerabathiran,Mohammed Vajagathali
Publisher
Springer Nature Singapore
Reference103 articles.
1. Addison CL (2006) Modulation of response to tumor therapies by the extracellular matrix. Future Oncol 2(3):417–429
2. Aguirre AJ, Bardeesy N, Sinha M, Lopez L, Tuveson DA, Horner J et al (2003) Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 17:3112–3126
3. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV et al (2013) Signatures of mutational processes in human cancer. Nature 500:415–421
4. Alisauskus R, Wong GY, Gold DV (1995) Initial studies of monoclonal antibody PAM4 targeting to xenografted orthotopic pancreatic cancer. Cancer Res 55(23 Suppl):5743s–5748s
5. Alves F, Contag S, Missbach M, Kaspareit J, Nebendahl K, Borchers U, Heidrich B, Streich R, Hiddemann W (2001) An orthotopic model of ductal adenocarcinoma of the pancreas in severe combined immunodeficient mice representing all steps of the metastatic cascade. Pancreas 23(3):227–235